Ironwood Q4 and FY 2022 Investor Update February 16, 2023 . Ironwood Safe Harbor Statement This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute on our vision; our strategy, business, financial position and operations, including with respect to our strategic priorities; the demand, development, commercial availability and commercial potential of linaclotide and the driv ...

Leading in GI through Growth and Innovation J.P. Morgan Healthcare Conference | January 11, 2023 Presented by Tom McCourt CEO, Ironwood Pharmaceuticals, Inc. Nasdaq: IRWD Safe Harbor Statement 2 This presentation contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability to execute on our vision; our strategy, business, financial position and operations, including with respect to our strategic prioritie ...